Patient Representative – Early Diagnosis Advisory Group
Cancer that’s diagnosed at an early stage is more likely to be treated successfully. The Early Diagnosis Advisory Group (EDAG) plays an important role in our strategy and work in this area. Join us to make sure the patient perspective is at the heart of this important group.
Early Diagnosis is a strategic priority for Cancer Research UK. Cancer that’s diagnosed at an early stage is more likely to be treated successfully.
The Early Diagnosis Advisory Group (EDAG) plays an important role in this area. The group advises CRUK on early diagnosis strategy, findings, messaging and policy. They also fund research and have built up a strong portfolio of published work which has impacted cancer policy and practice for earlier cancer diagnosis.
We are currently renewing the membership of EDAG and are seeking two Patient Representatives to ensure that the patient perspective is at the forefront of the conversations.
EDAG focuses on research that can be implemented in the short term and is likely to have impact on cancer policy. It’s therefore key that people affected by cancer are involved in the decision-making process of which projects should be funded or commissioned.
Closing date: Friday 4 October
Location: Meetings will be held in London
Payment and Expenses: Expenses will be paid in line with Cancer Research UK’s travel expense policy. You will also be able to claim an optional honorarium in recognition of the time spent attending the committee meetings and completing the meeting pre-work.
Time commitment: The membership term is 3 years, with two meetings per year (in May and November). Following this there may be an opportunity to continue for a second term.
How to get involved
If you’re passionate about early diagnosis, and have an interest in research, please email firstname.lastname@example.org for an application form and further details.
At CRUK we value diversity and we're committed to creating an inclusive environment which facilitates the involvement of all people affected by cancer. We actively encourage applications from people of all backgrounds and cultures and believe that a diverse involvement network (or range of views and insight) will help us to better represent people affected by cancer and make a difference for cancer patients.